Rivaroxaban versus nadroparin for thromboprophylaxis following thoracic surgery for lung cancer: A randomized, noninferiority trial

Mengmeng Zhao, Chang Chen, Chao Jiang et al.|American Journal of Hematology|2023

Cited by 15